What’s Driving bioAffinity Technologies’ Big Pre-Market Surge?

All NewsOctober 8, 2025

bioAffinity Technologies shares surged over 20% pre-market following a strong third-quarter sales update for its lung cancer diagnostic test.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

What’s Driving bioAffinity Technologies’ Big Pre-Market Surge?

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

Walmart’s bestselling $180 storage cabinet is 46% off

AMD’s biggest AI deals come with a 320 million share catch

Bank of America sends stark warning on Tripadvisor

Amazon’s 5.5-foot dual-zone storage shed has built-in shelves for $235

How the world became too reliant on Jensen Huang